Skip to main content
Have a personal or library account? Click to login
Priapism Associated with MethylphenidateSR (Concerta) Withdrawal Cover

Priapism Associated with MethylphenidateSR (Concerta) Withdrawal

Open Access
|Jul 2004

Full Article

A 15-year-old boy with attention deficit hyperactivity disorder, inattention subtype (ADHD), developed stuttering priapism (intermittent, prolonged, painful erections) after withdrawal of OROS methylphenidate (ConcertaR) 36 mg/day, and is reported from Inova Fairfax Hospital for Children, Falls Church, VA, and Children’s National Medical Center, Washington, DC. Symptoms began after the dose was increased from 27 mg/day to 36 mg/day, 6 days per week, with scheduled withdrawal on Sundays. Symptoms were exacerbated when a dose of 54 mg/day was prescribed later. An estimated 5 to 10 painful erections occurred on the first Sunday after one week of treatment, and each lasted 10 to 15 minutes or sometimes longer. On the following weekdays, erections recurred early AM on the school bus but stopped suddenly within 1 hour after taking the morning dose, only to return the following morning. After reducing the dose to 27 mg/day and gradually discontinuing treatment completely, symptoms immediately disappeared, with no recurrence of priapism at 6 months follow-up. Urinalysis for other drugs was negative. [1]

COMMENT. Priapism has been reported with sickle-cell hemoglobinopathy in children, but not with stimulant drugs. In the present case, the problem was not initially disclosed because of embarrassment, and further undiagnosed cases are possibly occurring.

Language: English
Page range: 51 - 52
Published on: Jul 1, 2004
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 2004 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.